EGFR is a potential dual molecular target for cancer and Alzheimer's disease
Many researchers are attempting to identify drugs that can be repurposed as effective therapies for Alzheimer's disease (AD). Several recent studies have highlighted epidermal growth factor receptor (EGFR) inhibitors approved for use as anti-cancer drugs as potential candidates for repurposing...
Saved in:
Main Authors: | Hee-Jeong Choi (Author), Yoo Joo Jeong (Author), Jieun Kim (Author), Hyang-Sook Hoe (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling
by: Hyun-ju Lee, et al.
Published: (2023) -
Analysis of the molecular subtypes of preoperative core needle biopsy and surgical specimens in invasive breast cancer
by: Ye Sul Jeong, et al.
Published: (2020) -
PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals
by: Ji Young Kim, et al.
Published: (2024) -
The lysosome as a novel therapeutic target of EGFR-mediated tumor inflammation
by: Woo Jung Sung, et al.
Published: (2022) -
Colon-targeted delivery of piceatannol enhances anti-colitic effects of the natural product: potential molecular mechanisms for therapeutic enhancement
by: Yum S, et al.
Published: (2015)